Persistent Disease clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
This phase II trial studies how well brivanib alaninate works in treating patients with cervical cancer that has come back. Brivanib alaninate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor.
San Francisco, California and other locations